SCHEMBL9360752

SCHEMBL9360752

O=c1[nH]cc(-c2ccc3ccccc3n2)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.46
RAB9A P51151 8/20 0.46
ALDH1A1 P00352 7/20 0.46
PKM P14618 4/20 0.46
HPGD P15428 4/20 0.46
HSD17B10 Q99714 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TP53 P04637 3/20 0.46
MAPT P10636 3/20 0.46
HCRTR1 O43613 1/20 0.46
GFER P55789 1/20 0.44
KDM4E B2RXH2 6/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 1/20 0.41
AR P10275 8/20 0.41
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29374931 0.70 RAB9A (0.64) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL170196 0.70 RAB9A (0.64) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL1365652 0.69 NPC1 (0.58) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL7377867 0.69 NPC1 (0.53) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL8783647 0.68 RAB9A (0.59) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL28598013 0.68 ALDH1A1 (0.50) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL29580854 0.68 RAB9A (0.59) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL10462487 0.68 CYSLTR2 (0.58) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL3698010 0.68 RAB9A (0.45) NPC1RAB9AALDH1A1PKMHPGD
SCHEMBL13700934 0.68 ALDH1A1 (0.63) NPC1RAB9AALDH1A1PKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365863-B1 Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors MERRELL DOW PHARMA (US) 1994-08-17 EP disclosed
EP-0428105-B1 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0428107-B1 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
US-4999431-A Reacting A Bromoquinoline Compound With Butyllithium And An N-Methyl-N-Methoxyalkanamide; Intermediates for Quinolyloxazole-2-ones MERRELL DOW PHARMACEUTICALS (US) 1991-03-12 US disclosed
US-4886811-A HYPOTENSIVE AGENTS AND VASODILATORS MERRELL DOW PHARMACEUTICALS (US) 1989-12-12 US disclosed